Dar Al Dawa Development and Investment Co. Ltd. (ASE:DADI)

Jordan flag Jordan · Delayed Price · Currency is JOD
1.230
-0.010 (-0.81%)
At close: Mar 1, 2026
-1.60%
Market Cap 58.04M
Revenue (ttm) 81.56M
Net Income (ttm) 6.61M
Shares Out 47.19M
EPS (ttm) 0.14
PE Ratio 8.79
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 138,138
Average Volume 191,096
Open 1.210
Previous Close 1.240
Day's Range 1.180 - 1.230
52-Week Range 1.090 - 1.310
Beta 0.25
RSI 53.92
Earnings Date Feb 12, 2026

About ASE:DADI

Dar Al Dawa Development and Investment Co. Ltd., an integrated pharmaceutical company, develops, manufactures, markets, and distributes pharmaceutical and consumer healthcare products in Levant, Gulf and Yemen, the Middle East, Africa, Europe, and Asia. The company offers products in the therapeutic areas of anti-infective, cardiovascular and diabetes, urology, respiratory, gastrointestinal, analgesic and musculoskeletal, central nervous system, gynecology, dermatology, ophthalmology, and oncology; and cereal and milk formula products for infan... [Read more]

Industry Pharmaceutical Preparations
Founded 1975
Employees 1,111
Stock Exchange Amman Stock Exchange
Ticker Symbol DADI
Full Company Profile

Financial Performance

In 2025, ASE:DADI's revenue was 81.56 million, an increase of 0.47% compared to the previous year's 81.18 million. Earnings were 6.61 million, an increase of 84.25%.

Financial Statements

News

There is no news available yet.